BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22556109)

  • 1. Prior choice in discrete latent modeling of spatially referenced cancer survival.
    Lawson AB; Choi J; Zhang J
    Stat Methods Med Res; 2014 Apr; 23(2):183-200. PubMed ID: 22556109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatially-explicit survival modeling with discrete grouping of cancer predictors.
    Onicescu G; Lawson AB; Zhang J; Gebregziabher M; Wallace K; Eberth JM
    Spat Spatiotemporal Epidemiol; 2019 Jun; 29():139-148. PubMed ID: 31128623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian accelerated failure time model for space-time dependency in a geographically augmented survival model.
    Onicescu G; Lawson A; Zhang J; Gebregziabher M; Wallace K; Eberth JM
    Stat Methods Med Res; 2017 Oct; 26(5):2244-2256. PubMed ID: 26220537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
    Kato I; Booza J; Quarshie WO; Schwartz K
    J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age, period and cohort effects in Bayesian smoothing of spatial cancer survival with geoadditive models.
    Sauleau EA; Hennerfeind A; Buemi A; Held L
    Stat Med; 2007 Jan; 26(1):212-29. PubMed ID: 16526007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian latent variable modelling of multivariate spatio-temporal variation in cancer mortality.
    Tzala E; Best N
    Stat Methods Med Res; 2008 Feb; 17(1):97-118. PubMed ID: 17855747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological subtypes of prostatic cancer: a comparative survival study.
    Kendal WS; Mai KT
    Can J Urol; 2010 Oct; 17(5):5355-9. PubMed ID: 20974026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial variation in prostate cancer survival in the Northern and Yorkshire region of England using Bayesian relative survival smoothing.
    Fairley L; Forman D; West R; Manda S
    Br J Cancer; 2008 Dec; 99(11):1786-93. PubMed ID: 18985045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Period analysis of prostate cancer survival.
    Wilding G; Remington P
    J Clin Oncol; 2005 Jan; 23(3):407-9. PubMed ID: 15572729
    [No Abstract]   [Full Text] [Related]  

  • 10. Bayesian random-effects threshold regression with application to survival data with nonproportional hazards.
    Pennell ML; Whitmore GA; Ting Lee ML
    Biostatistics; 2010 Jan; 11(1):111-26. PubMed ID: 19828558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian area-age-period-cohort model with carcinogenesis age effects in estimating cancer mortality.
    Xu Z; Hertzberg VS
    Cancer Epidemiol; 2013 Oct; 37(5):593-600. PubMed ID: 23891684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bayesian normal mixture accelerated failure time spatial model and its application to prostate cancer.
    Wang S; Zhang J; Lawson AB
    Stat Methods Med Res; 2016 Apr; 25(2):793-806. PubMed ID: 23117407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dimensional variable selection and prediction under competing risks with application to SEER-Medicare linked data.
    Hou J; Paravati A; Hou J; Xu R; Murphy J
    Stat Med; 2018 Oct; 37(24):3486-3502. PubMed ID: 29845637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current developments in biostatistics].
    Richardson S
    Rev Epidemiol Sante Publique; 1996 Nov; 44(6):482-93. PubMed ID: 9005485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling geographically referenced survival data with a cure fraction.
    Cooner F; Banerjee S; McBean AM
    Stat Methods Med Res; 2006 Aug; 15(4):307-24. PubMed ID: 16886733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian variable selection in the accelerated failure time model with an application to the surveillance, epidemiology, and end results breast cancer data.
    Zhang Z; Sinha S; Maiti T; Shipp E
    Stat Methods Med Res; 2018 Apr; 27(4):971-990. PubMed ID: 28034170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bayesian space varying parameter model applied to estimating fertility schedules.
    Assunção RM; Potter JE; Cavenaghi SM
    Stat Med; 2002 Jul; 21(14):2057-75. PubMed ID: 12111887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian analysis for generalized linear models with nonignorably missing covariates.
    Huang L; Chen MH; Ibrahim JG
    Biometrics; 2005 Sep; 61(3):767-80. PubMed ID: 16135028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer survival in five continents: a worldwide population-based study (CONCORD).
    Coleman MP; Quaresma M; Berrino F; Lutz JM; De Angelis R; Capocaccia R; Baili P; Rachet B; Gatta G; Hakulinen T; Micheli A; Sant M; Weir HK; Elwood JM; Tsukuma H; Koifman S; E Silva GA; Francisci S; Santaquilani M; Verdecchia A; Storm HH; Young JL;
    Lancet Oncol; 2008 Aug; 9(8):730-56. PubMed ID: 18639491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parametric models for spatially correlated survival data for individuals with multiple cancers.
    Diva U; Dey DK; Banerjee S
    Stat Med; 2008 May; 27(12):2127-44. PubMed ID: 18167633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.